Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2023-01-31 Declaration of Voting R…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (951 characters) and announces the company's share capital ('Aktiekapital') and votes ('stemmer') as of January 31, 2023, referencing Danish capital markets law (§ 32 i lov om kapitalmarkeder). It details the nominal share capital (DKK 44,379,620) split into A and B shares. This type of announcement, which reports on the structure of the company's capital and voting rights, fits best under 'Declaration of Voting Results & Voting Rights Announcements' (DVA) or potentially 'Share Issue/Capital Change' (SHA). Since it explicitly states the current capital structure and total votes, DVA is the most precise fit, as it relates directly to shareholder rights and voting power, even if it's not the result of a specific vote, but rather a statutory disclosure of the voting base. Given the options, DVA is the strongest match for a formal declaration of capital and voting rights.
2023-01-31 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change Classification · 99% confidence The document text is a formal announcement from Blue Vision A/S regarding the allocation of bonus shares ('tildeling af fondsandele'). This action involves increasing the company's share capital by issuing new A-shares and B-shares to existing shareholders free of charge, effectively changing the capital structure. This directly aligns with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. Although it involves shares, it is a capital structure change via bonus issue rather than a direct buyback (POS) or a general share issue for cash/acquisition (SHA). Given the nature of the capital structure adjustment, CAP is the most appropriate classification.
2023-01-25 Danish
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement Classification · 99% confidence The document is titled "FULDMAGTSBLANKET" (Proxy Form/Power of Attorney Form) and explicitly relates to an 'ekstraordinær generalforsamling' (extraordinary general meeting) for Blue Vision A/S. It provides options for shareholders to grant proxies (fuldmagt) to a named third party or the board of directors to vote on specific agenda items (Dagsordenspunkter), such as proposals regarding share class consolidation and auditor election. This content is characteristic of materials used to solicit shareholder votes ahead of a general meeting, which aligns directly with the definition of Proxy Solicitation & Information Statement (PSI).
2023-01-19 Danish
Indkaldelse til ekstraordinær generalforsamling i Blue Vision A/S ("Blue Vision"), den 10. februar 2023, kl. 14.00
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a registration form ('Tilmeldingsblanket') for an Extraordinary General Meeting (ekstraordinær generalforsamling) for Blue Vision A/S. It provides instructions for shareholders to request admission cards and voting materials. This type of document is a standard proxy solicitation or meeting registration material sent to shareholders to facilitate their participation in a corporate meeting.
2023-01-19 Danish
Indkaldelse til ekstraordinær generalforsamling i Blue Vision A/S ("Blue Vision"), den 10. februar 2023, kl. 14.00
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Brevstemme' (postal vote) form for an extraordinary general meeting of Blue Vision A/S. It provides shareholders with the ability to cast votes on specific agenda items (such as share class consolidation and name changes) prior to the meeting. This document is a standard proxy solicitation material used to gather shareholder votes for a meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-01-19 Danish
Indkaldelse til ekstraordinær generalforsamling i Blue Vision A/S ("Blue Vision"), den 10. februar 2023, kl. 14.00
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an 'Indkaldelse til ekstraordinær generalforsamling' (Notice of Extraordinary General Meeting) for Blue Vision A/S. It outlines the agenda for the meeting, including proposals for share class consolidation, name changes, and auditor selection, along with detailed proposed amendments to the company's articles of association. This document is a formal notice sent to shareholders to provide information and request votes for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2023-01-19 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.